Streetbeat News

Products Services

HYMTF

TSLA

Hyundai's IONIQ 5 robotaxi, developed in collaboration with Motional, has passed a simulated driving test, showcasing its autonomous driving capabilities. The test, part of a campaign film, was conducted in Las Vegas and featured a simulation of a U.S. driver's license test. The IONIQ 5 is currently transporting passengers in select areas of Las Vegas via the Uber app, with a vehicle operator present. Meanwhile, Tesla is preparing to unveil its own self-driving robotaxi on August 8, with CEO Elon Musk emphasizing the importance of vehicle autonomy to the company's value.

Portfolio Pulse from Anan Ashraf

April 15, 2024 | 12:16 pm

CELU

Celularity Inc. (NASDAQ:CELU) announced its Q1 2024 net sales for advanced biomaterial products and biobanking businesses are trending ahead of previous expectations. The company is experiencing its 4th consecutive quarter of sales growth and is implementing SG&A reductions, including executive pay cuts, to invest in production expansion. Celularity's product pipeline includes four commercial-stage products (Biovance®, Biovance® 3L, Interfyl®, CentaFlex®) and three investigational products, with a focus on leveraging its placental-derived technology across various medical indications.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:15 pm

URGN

UroGen Pharma Ltd. (NASDAQ:URGN) announced FDA acceptance of its IND application for UGN-103, a novel mitomycin-based formulation for treating low-grade intermediate-risk non-muscle invasive bladder cancer. UroGen plans to initiate a Phase 3 study in 2024, with potential advantages including a new 80 mg dosage strength, simplified manufacturing, and extended intellectual property protection until December 2041. UGN-103 utilizes UroGen's RTGel platform technology. Additionally, UroGen is preparing for an NDA submission for UGN-102, another mitomycin formulation, in September 2024.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:11 pm

VSTE

Vast Renewables has signed engineering contracts with Afry, FYFE, Primero, and Worley for the front-end engineering design of the VS1 project, a 30MW / 288 MWh CSP plant in Port Augusta, South Australia. The project, leveraging Vast's modular tower CSP v3.0 technology, aims to produce clean, low-cost, dispatchable power and includes over 8 hours of thermal energy storage. It is expected to generate numerous green manufacturing jobs, hundreds of construction jobs, and long-term operational roles.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:10 pm

EQIX

Equinix, Inc. (NASDAQ:EQIX) and PGIM Real Estate have announced a $600 million joint venture to develop and operate the first xScale data center in the U.S., located in Silicon Valley. The facility, named SV12x, will offer over 28 MW of power capacity and is part of Equinix's global xScale data center portfolio, expected to exceed $8 billion and 725 MW across more than 35 facilities. PGIM Real Estate will hold an 80% equity interest, with Equinix holding the remaining 20%. This venture marks PGIM Real Estate's first investment through its global data center strategy.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:09 pm

HYMTF

Kia, a subsidiary of Hyundai Motor (OTC:HYMTF), has launched a cash incentive program for U.S. dealers to clear inventory of 2023 EV models and make room for 2024 models. The 'Kia April 2024 Dealer Flat Cash Program' offers $1,000 for each 2023 EV6 sold, $1,500 for the EV6 GT, and smaller incentives for 2024 models. Despite a slight drop in total vehicle sales, Kia's EV sales in the U.S. have significantly increased, with a notable jump in EV9 and EV6 sales.

Portfolio Pulse from Anan Ashraf

April 15, 2024 | 12:08 pm

AKTX

Akari Therapeutics announced it will present pre-clinical electroretinography data for PAS-Nomacopan at ARVO 2024. This presentation could highlight potential advancements in their research and development efforts.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:07 pm

NGMS

NeoGames S.A (NASDAQ:NGMS) has partnered with BIG Brazil to enter Brazil's newly regulated iGaming market with the Caesars Brazil brand. This deal includes NeoGames providing its gaming platform, sportsbook solution, and other services to support BIG Brazil's ambition to become a leading operator in Brazil. The partnership follows BIG Brazil's licensing agreement with Caesars Entertainment for the Caesars brand in Brazil.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:06 pm

ONVO

Organovo announced positive Phase 2 results for FXR314, showing a statistically significant reduction in liver fat content from baseline in study subjects.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:06 pm

A

Agilent Technologies, Inc. has received the European IVDR Class C certification for its GenetiSure Dx Postnatal Assay, marking a significant regulatory milestone that allows the product to be sold across Europe. This certification is crucial for diagnostic tests in the European market, indicating that Agilent's assay meets high safety, quality, and performance standards.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:03 pm